Inventor · disambiguated record
Holger Rosenbrock
Also filed as: ROSENBROCK HOLGER
14 granted patents·4 pending applications·39 citations·filing 2008–2024
90Inventor score
Files withBOEHRINGER INGELHEIM INT8GIOVANNINI RICCARDO5HEINE NIKLAS2EICKMEIER CHRISTIAN1FUCHS KLAUS1
Top patents by PatentIndex Score
18 records- 0182US8648085B21, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disordersEICKMEIER CHRISTIAN·Filed 2008·Granted Feb 11, 2014·8 cites·9 claims
- 0282US8623879B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2009·Granted Jan 7, 2014·5 cites·39 claims
- 0380US9102679B2Compounds for the treatment of CNS disordersGIOVANNINI RICCARDO·Filed 2013·Granted Aug 11, 2015·5 cites·5 claims
- 0479US10793634B2Anti-TrkB antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Oct 6, 2020·3 cites·38 claims
- 0578US8912201B26-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disordersHEINE NIKLAS·Filed 2011·Granted Dec 16, 2014·4 cites·25 claims
- 0677US9096603B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2013·Granted Aug 4, 2015·3 cites·4 claims
- 0776US8623901B2Compounds for the treatment of CNS disordersGIOVANNINI RICCARDO·Filed 2010·Granted Jan 7, 2014·3 cites·22 claims
- 0875US12059408B2Treatment of cognitive impairment associated with schizophreniaBOEHRINGER INGELHEIM INT·Filed 2021·Granted Aug 13, 2024·1 cites·24 claims
- 0974US9328120B26-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disordersHEINE NIKLAS·Filed 2014·Granted May 3, 2016·2 cites·19 claims
- 1074US9079905B2Compounds for the treatment of CNS disordersFUCHS KLAUS·Filed 2009·Granted Jul 14, 2015·2 cites·4 claims
- 1174US2024101689A1Anti-trkb antibodiesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1272US9012489B2Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicamentGIOVANNINI RICCARDO·Filed 2012·Granted Apr 21, 2015·2 cites·47 claims
- 1362US11866501B2Anti-TrkB antibodiesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 9, 2024·0 cites·1 claims
- 1462US9233953B2Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1HOENKE CHRISTOPH·Filed 2014·Granted Jan 12, 2016·1 cites·18 claims
- 1560US2024335426A1Treatment of cognitive impairment associated with schizophreniaBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1655US10919898B2Medical use of compound IIIBOEHRINGER INGELHEIM INT·Filed 2018·Granted Feb 16, 2021·0 cites·4 claims
- 1748US2021130362A1Medical use of compound iiiBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1836US2011212960A1New compounds for the treatment of cns disorderBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holger Rosenbrock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →